Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Cash from Investing Activities (2019 - 2025)

Pulmonx has reported Cash from Investing Activities over the past 7 years, most recently at $8.7 million for Q3 2025.

  • Quarterly Cash from Investing Activities rose 29.03% to $8.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $44.6 million through Sep 2025, up 6713.76% year-over-year, with the annual reading at $17.5 million for FY2024, 970.75% up from the prior year.
  • Cash from Investing Activities was $8.7 million for Q3 2025 at Pulmonx, up from $5.5 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $16.3 million in Q1 2025 and troughed at -$29.1 million in Q4 2021.
  • The 5-year median for Cash from Investing Activities is -$727000.0 (2022), against an average of -$237684.2.
  • Year-over-year, Cash from Investing Activities tumbled 4392.11% in 2021 and then soared 2143.18% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$29.1 million in 2021, then skyrocketed by 97.5% to -$727000.0 in 2022, then crashed by 278.95% to -$2.8 million in 2023, then soared by 610.6% to $14.1 million in 2024, then crashed by 38.07% to $8.7 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Cash from Investing Activities are $8.7 million (Q3 2025), $5.5 million (Q2 2025), and $16.3 million (Q1 2025).